Advanced search×

Joint Bone Spine

Print ISSN
1297-319X
Electronic ISSN
1778-7254
Impact factor
2.46
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/1297319X
Usage rank
3462
Article count
1949
Free count
13
Free percentage
0.00667009
PDFs via platforms
CSA, Rcgp, Gale, Sciencedirect from 2000, Proquest, and Ingenta

  1. Current Treatment of Psoriatic Arthritis: Update Based on a Systematic Literature Review to Establish French Society for Rheumatology (SFR) Recommendations for Managing Spondyloarthritis

    Joint Bone Spine 82(2) (2015) PMID 24997741

    Objective The latest recommendations on managing psoriatic arthritis (PsA) were issued in 2007 by the French Society for Rheumatology (SFR) and in 2012 by the European League against Rheumatism (EULAR). A panel of spondyloarthritis experts developed new recommendations on the...
  2. Why are rheumatologists still reluctant to perform joint-fluid analysis?

    Joint Bone Spine (2015)

  3. Is there a role for imatinib mesylate in the treatment of eosinophilic granulomatosis with polyangiitis?

    Joint Bone Spine 82(1):72 (2015) PMID 25059880

  4. Pulmonary hyalinizing granuloma associated with Sjögren syndrome and ANCA MPO vasculitis

    Joint Bone Spine 82(1):71 (2015) PMID 25048101

  5. CV2 :Editorial Board
    Author(s) unavailable

    Joint Bone Spine 82(1):IFC (2015)

  6. Validation of the 2010-ACR/EULAR – classification criteria using newly EULAR-defined erosion for rheumatoid arthritis on the very early arthritis community-based (VErA) cohort

    Joint Bone Spine 82(1):38 (2015) PMID 25304188

    Objective To validate the 2010-ACR/EULAR criteria for rheumatoid arthritis (RA), taking into account the recent EULAR definition of “erosive disease”, on the 310 patients comprising the very early arthritis cohort (VErA).
  7. Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience

    Joint Bone Spine 82(1):31 (2015) PMID 25311253

    Objective To evaluate the performance of anti-TNFα therapy in psoriatic arthritis (PsA) in a routine care setting.
  8. Essential role for CD103+ cells in the pathogenesis of spondyloarthritides

    Joint Bone Spine 82(1):8 (2015) PMID 25241337

    The clinical features of spondyloarthritides include extraarticular manifestations involving the skin, eyes, and gastrointestinal tract. At these sites, a membrane integrin can be acquired by virtue of the presence of CD4+ T cells and specific dendritic cells and correlates with a regu...
  9. Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR

    Joint Bone Spine 82(1):13 (2015) PMID 25238951

    ESPOIR is a French multicenter cohort of patients with undifferentiated arthritis enrolled within six months of symptom onset, naive to disease-modifying antirheumatic drugs and corticosteroid therapy, and either having rheumatoid arthritis (RA) or being at risk for progression to RA. ...
  10. The IL-23/Th 17 Pathway in Spondyloarthritis: The Royal Road?

    Joint Bone Spine 82(1) (2015) PMID 25245641